Thread builds in decentralized trials again with CureClick buy

Just over a year after partnering on a project to accelerate recruitment into decentralized clinical trials (DCTs), Thread and CureClick have decided to formally tie the knot.

The marriage brings together Thread’s artificial intelligence and machine learning-based DCT platform – designed to make it easier for trial sponsors to run remote studies – and CureClick’s community-powered approach to patient recruitment.